Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody – Business Wire

Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody – Business Wire

Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody – Business Wire
Published on 2019-07-03